We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Updated Labeling for Laparoscopic Power Morcellators
FDA Seeks Updated Labeling for Laparoscopic Power Morcellators
The FDA issued a final guidance recommending that devicemakers include more specific information in the labeling of laparoscopic power morcellators (LPMs) on the risk of spreading benign uterine tissue and on the use of LPM containment systems.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor